Free Trial

300,000 Shares in Anteris Technologies Global Corp (NASDAQ:AVR) Purchased by Affinity Asset Advisors LLC

Anteris Technologies Global logo with Medical background

Affinity Asset Advisors LLC bought a new stake in shares of Anteris Technologies Global Corp (NASDAQ:AVR - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 300,000 shares of the company's stock, valued at approximately $1,674,000. Affinity Asset Advisors LLC owned about 0.83% of Anteris Technologies Global as of its most recent filing with the Securities and Exchange Commission.

Separately, ADAR1 Capital Management LLC bought a new stake in Anteris Technologies Global during the fourth quarter valued at about $5,876,000.

Anteris Technologies Global Stock Up 1.1 %

AVR traded up $0.03 during trading hours on Friday, hitting $2.88. 269,456 shares of the company's stock were exchanged, compared to its average volume of 210,228. Anteris Technologies Global Corp has a 12-month low of $2.34 and a 12-month high of $8.79. The stock's 50 day moving average price is $5.59.

Analyst Upgrades and Downgrades

AVR has been the topic of several recent analyst reports. Barclays initiated coverage on shares of Anteris Technologies Global in a report on Tuesday, January 7th. They set an "overweight" rating and a $22.00 price objective on the stock. Lake Street Capital started coverage on Anteris Technologies Global in a report on Wednesday, January 8th. They set a "buy" rating and a $20.00 target price for the company. Cantor Fitzgerald began coverage on shares of Anteris Technologies Global in a research note on Tuesday, January 7th. They issued an "overweight" rating and a $9.00 price target for the company. Finally, TD Cowen started coverage on shares of Anteris Technologies Global in a research report on Tuesday, January 7th. They set a "buy" rating and a $15.00 price target on the stock.

View Our Latest Analysis on Anteris Technologies Global

About Anteris Technologies Global

(Free Report)

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Further Reading

Institutional Ownership by Quarter for Anteris Technologies Global (NASDAQ:AVR)

Should You Invest $1,000 in Anteris Technologies Global Right Now?

Before you consider Anteris Technologies Global, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anteris Technologies Global wasn't on the list.

While Anteris Technologies Global currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In
5 Stocks to BUY NOW in May 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines